As a result of possible for really serious adverse reactions in infants from mitoxantrone, breastfeeding needs to be discontinued before beginning treatment. Patients who experienced an incomplete antileukemic response been given a next induction training course during which mitoxantrone or daunorubicin was administered for two times and cytarabine for five https://richardo776jbt7.blogsumer.com/profile